AG
CSCI

Aperio Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Aperio Group’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-6
Closed -$82K – 1914
2014
Q3 		$82K Hold
6
– – ﹤0.01% 1696
2014
Q2 		$71K Hold
6
– – ﹤0.01% 1699
2014
Q1 		$72K Buy
+6
New +$77.4K ﹤0.01% 1990
2013
Q4 		– Hold
0
– – – 1924

Other funds holding CSCI

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Aperio Group's CSCI Position: Q4 2014 in Review

Aperio Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2014, closing a stake of 6 shares — an estimated $82K sold.

Aperio Group first reported a position in CSCI in Q1 2014 and held it in 3 quarters. The position peaked at $82K in Q3 2014. 18 funds tracked by Wall St. Rank hold CSCI as of Q4 2014.

  • Aperio Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Aperio Group sold 6 COSCIENS Biopharma Inc. Common Stock shares in Q4 2014, an estimated $82K.
  • Aperio Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2014 and held it in 3 quarters.
  • Aperio Group's COSCIENS Biopharma Inc. Common Stock position peaked at $82K in Q3 2014.
  • 18 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2014.

Based on Aperio Group's 13F filing for Q4 2014, filed 30 Jan 2015.